SynthesisBMC cardiovascular disorders2025
Current guidelines in hypertension management with special focus on management of extremely high blood pressure: a systematic review.
Synthesis in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Comparative effectiveness and safety of oral antihypertensive agents for severe asymptomatic hypertension: A systematic review and network meta-analysis of randomized controlled trials.Hypertension research : official journal of the Japanese Society of Hypertension · 2026Article
- Disease risk perception, health intervention intention and their influencing factors among prehypertensive and hypertensive populations: a cross-sectional study with 1050 participants.BMC public health · 2026Article
- PROMBot-HSM-AF: protocol for a feasibility study of a chatbot-based platform to collect patient-reported outcomes after atrial fibrillation ablation.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeHypertension (HTN) represents a significant global health issue and markedly elevates the risk of cardiovascular diseases, stroke, and chronic kidney disease. This study examined various hypertension management guidelines, including the management of hypertensive crises, hypertension in adults and the elderly, and hypertension-related complications. Additionally, it examined blood pressure (BP) objectives. MATERIALS AND
methodsA comprehensive search was conducted in PubMed, Scopus, and Web of Science databases, with a publication period restriction of 2010-2025. Seventeen guidelines were included and reviewed. Data on managing hypertensive crises and increased BP, including optimal BP goals, medications, and follow-up, were extracted. Data on the treatment of hypertension in patients with various End-Organ Damage (EOD) were also collected.
resultsBP ≥ 180/120 mmHg with EOD has been defined as an emergency, requiring a reduction of BP by 20-25% within the first hour, followed by a gradual decrease. Ischemic stroke was the most commonly discussed EOD (n = 8), with a target BP range of 130-180/90-105 mmHg. Elevated BP has been defined as BP ≥ 130/80 mmHg to ≥ 140/90 mmHg (n = 12), and guidelines recommend different management strategies.
conclusionLittle data exist on how to treat high blood pressure in inpatient settings and hospitalized patients, despite the existence of sufficient guidelines and statements offering recommendations for controlling hypertension in outpatient settings. Although the guidelines suggest that patients with markedly elevated BP should be treated in inpatient settings, further research is needed to close the knowledge gaps in this area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.